Biohybrid systems allow for new applications in food technology, molecular biology, medical diagnostics, and pharmaceutical industry
Cells, biological circuits, and individual biomolecules organize themselves and interact with the environment. Use of these capabilities in flexible and economically efficient biotechnological production systems is in the focus of the “Molecular Interaction Engineering” (MIE) project. It is the objective to develop printed biological circuits and catalysts for biologico-technical hybrid systems. MIE will be funded with about EUR 3.5 million by the BMBF.
The capabilities of biological systems are based on specific interactions of molecular components. Due to their molecular fitting accuracy, for instance, enzymes allow for certain chemical reactions only. Some proteins bind via specific molecular interfaces to the DNA or other proteins and control processes in complex organisms. Sensors respond to defined molecular signals from the environment. The MIE project focuses on interactions of molecules, technical interfaces, and surrounding solvents.
“Transfer of complex biological mechanisms to printable systems may result in innovative biotechnologies that might be the basis of a number of industrial applications,” Professor Jürgen Hubbuch, project coordinator at KIT, explains. However, conventional, continuous evolution of biological molecules reaches its limits. The key to innovative developments is the specific, adjusted construction of the interaction of complex biomolecules and fusion of these units with technical interfaces. This requires close cooperation of biology, engineering, chemistry, and physics.
The “Molecular Interaction Engineering” (MIE) project combines methods of biotechnology, structural biology, materials sciences, process engineering, and computer simulation. Work is aimed at developing innovative, flexible, and economically efficient biotechnological production systems for molecules. These might then be used in biohybrid systems integrating biological and electronic components. Biohybrid systems allow for new applications in food technology, molecular biology, medical diagnostics, and pharmaceutical industry.
The Latest on: Printable Biotechnology
- Israeli Scientists Engineer Tissue Implants Using Patients’ Own Cells on November 13, 2018 at 6:15 am
Professor Tal Dvir of TAU’s Department of Biotechnology, Department of Materials ... Israeli Scientists Unveil New Tech To 3D-Print Personalized Drugs“Since both the cells and the material ... […]
- Samsung's hopes for biotech arm hinge on fraud ruling on November 13, 2018 at 1:39 am
SEOUL -- Samsung's long-term growth strategy will come under scrutiny on Wednesday when South Korean regulators review allegations of accounting fraud at the group's biotech arm, its vehicle for ... […]
- Scientists 3D print a bionic mushroom to generate bioelectricity on November 12, 2018 at 10:16 am
Scientists at the Stevens Institute of Technology, New Jersey, 3D printed what they’re calling a “bionic mushroom” capable of generating electricity. Revealed in a study published in Nano ... […]
- Moderna aims to raise $500 million in biotech’s largest-ever public offering on November 9, 2018 at 12:08 pm
Moderna Therapeutics, a Cambridge biotech valued at more than $7 billion, is plotting to raise $500 million in what would be the sector’s largest-ever initial public offering. The company filed with t... […]
- Various Technological Advancements are set to Grow the Global Biotechnology Market on November 9, 2018 at 6:30 am
Now, technological advancements, such as artificial intelligence, are being used within the biotechnology industry to manufacture ... or presentations that it publishes electronically or in print. Inv... […]
via Google News and Bing News